Tocilizumab for giant cell arteritis: what is optimal?

被引：0
|
作者：
Kaymakci, M. [1 ]
Warrington, K. J. [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Rheumatol, 200 First St SW, Rochester, MN 55905 USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2023年 / 41卷 / 04期
关键词：
giant cell arteritis; tocilizumab; vasculitis; COHORT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [1] Tocilizumab in giant cell arteritis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (02): : E100 - E100
  • [2] Tocilizumab in Giant Cell Arteritis
    Mariano, Vincent J.
    Frishman, William H.
    [J]. CARDIOLOGY IN REVIEW, 2018, 26 (06) : 321 - 330
  • [3] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [4] Tocilizumab in Giant Cell Arteritis
    Pflugfelder, J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 87 - 88
  • [5] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [6] Tocilizumab (Actemra) for Giant Cell Arteritis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1530): : 161 - 162
  • [7] Tocilizumab for the treatment of giant cell arteritis
    Schirmer, Michael
    Muratore, Francesco
    Salvarani, Carlo
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 339 - 349
  • [8] Tocilizumab in the treatment of giant cell arteritis
    Leuchten, Nicolai
    Aringer, Martin
    [J]. IMMUNOTHERAPY, 2018, 10 (06) : 465 - 472
  • [9] Efficacy of tocilizumab in refractory giant cell arteritis
    Vinit, Julien
    Bielefeld, Philip
    Muller, Geraldine
    Besancenot, Jean-Francois
    [J]. JOINT BONE SPINE, 2012, 79 (03) : 317 - 318
  • [10] Trial of Tocilizumab in Giant-Cell Arteritis
    Akiyama, Mitsuhiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1493 - 1494
12345